Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of September 14, 2026, TMO trades at $608.70 with a market cap of $225.48B and a P/E ratio of 32.65. TMO moved +0.18% today. Year to date, TMO is +4.52%; over the trailing twelve months it is +24.10%. Its 52-week range spans $385.46 to $647.00. Analyst consensus is strong buy with an average price target of $643.50. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Thermo Fisher (TMO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TMO moved +0.18% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $608.70 |
| Market Cap | $225.48B |
| P/E Ratio | 32.65 |
| EPS | $18.62 |
| Dividend Yield | 0.47% |
| 52-Week High | $647.00 |
| 52-Week Low | $385.46 |
| Volume | 119.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $46.34B |
| Net Income | $6.99B |
| Gross Margin | 0.00% |
19 analysts cover TMO: 0 strong buy, 16 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $643.50.